Woo hoo! Taking out some of the toxics. If the n
Post# of 30067
Posted On: 01/27/2016 3:37:47 PM
Woo hoo! Taking out some of the toxics. If the new investors won't convert and dump, this is good.
Amarantus Announces $1M Investment
SAN FRANCISCO, January 27, 2016 /PRNewswire/ --
Amarantus BioScience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing products in Regenerative Medicine, Neurology and Orphan diseases, today announced the closing of a $1M investment from an investor introduced to the Company by International Infusion, LLC. The new investment comes in the form of Series H Convertible Preferred Stock and Warrants on the same terms as previously disclosed. As part of the agreement, the Company's 2 largest institutional investors have agreed to certain trading restrictions over the course of the next 7 weeks.
Concurrent with this announcement, the Company has entered into an agreement with International Infusion to provide funding of up to $1.5M over the course of the next five weeks to be used solely for the partial repurchase of Convertible Preferred Stock from Company's 2 largest institutional investors.
Amarantus Announces $1M Investment
SAN FRANCISCO, January 27, 2016 /PRNewswire/ --
Amarantus BioScience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing products in Regenerative Medicine, Neurology and Orphan diseases, today announced the closing of a $1M investment from an investor introduced to the Company by International Infusion, LLC. The new investment comes in the form of Series H Convertible Preferred Stock and Warrants on the same terms as previously disclosed. As part of the agreement, the Company's 2 largest institutional investors have agreed to certain trading restrictions over the course of the next 7 weeks.
Concurrent with this announcement, the Company has entered into an agreement with International Infusion to provide funding of up to $1.5M over the course of the next five weeks to be used solely for the partial repurchase of Convertible Preferred Stock from Company's 2 largest institutional investors.
(0)
(0)